(INNS)
ABITUZUMAB(INND)
ABITUZUMAB(INNC)
IMMUNOGLOBULIN G2-KAPPA, ANTI-[HOMO SAPIENS ITGAV (INTEGRIN ALPHAV, CD51)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN (1-447) WITH IGHG1 HINGE REGION [HUMANIZED VH (HOMO SAPIENS IGHV1-46*01 (77.30%) -(IGHD)-IGHJ6*01) [8.8.11] (1-118) -HOMO SAPIENS IGHG (IGHG2*03 CH1 (119-216), IGHG1 HINGE C5>S (221) (217-231), IGHG2*03 CH2 F84.3>A (296), N84.4>Q (297) (232-340), CH3 (341-445), CHS (446-447)) (119- 447)], (132-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (86.30%) -IGKJ2*01) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')]; DIMER (227-227":230- 230")-BISDISULFIDE, RECOMMENDED INN: LIST 71(WHO)
ABITUZUMABUM(INN)